The role of the microbiome in cancer is an area of intense research, as scientists uncover the complex relationship between the microorganisms residing in our bodies and cancer development. Studies have shown that the gut microbiome can influence immune responses, inflammation, and the effectiveness of cancer therapies. Some microbiota may promote carcinogenesis by producing metabolites that alter the tumor microenvironment, while others may have protective effects. Researchers are investigating how the microbiome can be modulated to enhance cancer treatments, such as immunotherapy or chemotherapy. Understanding these interactions could lead to the development of microbiome-based therapies, such as probiotics or dietary interventions, to improve cancer treatment outcomes and reduce side effects.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States